Recent News

• 12.02.2025 - Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
• 12.02.2025 - Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc
• 11.18.2025 - Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
• 09.19.2025 - Sonnet to Present at the MedInvest Biotech & Pharma Conference

Recent Filings

• 12.02.2025 - 8-K Current report
• 12.02.2025 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
• 12.02.2025 - EX-99.1 EX-99.1
• 11.19.2025 - 425 Prospectuses and communications, business combinations
• 11.19.2025 - 425 Prospectuses and communications, business combinations
• 11.18.2025 - 8-K Current report
• 11.18.2025 - 425 Prospectuses and communications, business combinations
• 11.18.2025 - EX-99.1 EX-99.1
• 11.18.2025 - 425 Prospectuses and communications, business combinations
• 11.18.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material